{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:27:47Z","timestamp":1761157667269,"version":"3.40.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.transproceed.2024.08.028","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T20:30:22Z","timestamp":1725395422000},"page":"1878-1884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Cytomegalovirus Reactivation in Children After Allogeneic Hematopoietic Cell Transplantation in 2 Transplant Eras"],"prefix":"10.1016","volume":"56","author":[{"given":"Yu-Chuan","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Yen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-1555","authenticated-orcid":false,"given":"Tang-Her","family":"Jaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.08.028_bib0001","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-med-042921-124739","article-title":"Cytomegalovirus therapy: role of letermovir in prophylaxis and treatment in transplant recipients","volume":"74","author":"Saullo","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0002","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.3390\/jcm11133832","article-title":"The role of CMV infection in primary lesions, development and clinical expression of atherosclerosis","volume":"11","author":"Cristescu","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0003","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0004","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41409-022-01863-8","article-title":"New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working Pary of EBMT","volume":"58","author":"Cesaro","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0005","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/bloodadvances.2019000627","article-title":"Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy","volume":"3","author":"Solomon","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11899-018-0462-x","article-title":"Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia; current evidence, and improving outcomes going forward","volume":"13","author":"Leonard","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPH.0000000000000730","article-title":"Cytomegalovirus treatment in pediatric hematopoietic stem cell transplant patients","volume":"39","author":"Wattles","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0008","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/bloodadvances.2021005885","article-title":"Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease","volume":"6","author":"Akahoshi","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for Transplantation and Cellular Therapy Series: #3-prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0011","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1097\/MPH.0000000000002467","article-title":"Threshold of quantitative cytomegalovirus DNA PCR for preemptive treatment in pediatric hematopoietic stem cell transplant recipients","volume":"45","author":"Ahn","year":"2023","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0012","doi-asserted-by":"crossref","first-page":"e15300","DOI":"10.1111\/ctr.15300","article-title":"Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients","volume":"38","author":"Cui","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0013","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/pharmaceutics15010163","article-title":"Optimizing antiviral dosing for HSV and CMV treatment in immunocompromised patients","volume":"15","author":"Huntjens","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0014","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cix793","article-title":"Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"Razonable","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0016","doi-asserted-by":"crossref","first-page":"e30608","DOI":"10.1002\/pbc.30608","article-title":"Letermovir for cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation","volume":"70","author":"Chen","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0017","doi-asserted-by":"crossref","first-page":"e14104","DOI":"10.1111\/tid.14104","article-title":"Cytomegalovirus immune reconstitution in cord blood transplant recipients on letermovir prophylaxis","volume":"25","author":"Abidi","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0018","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.jtct.2022.10.005","article-title":"Letermovir as cytomegalovirus prophylaxis in a pediatric cohort: a retrospective analysis","volume":"29","author":"Kuhn","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0019","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41409-023-01944-2","article-title":"CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality","volume":"58","author":"Eberhardt","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0020","doi-asserted-by":"crossref","first-page":"11785","DOI":"10.3389\/ti.2023.11785","article-title":"New treatment options for refractory\/resistant CMV infection","volume":"36","author":"Walti","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0021","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/1878-0261.12895","article-title":"Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy","volume":"15","author":"Li","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.transproceed.2024.08.028_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/vaccines11010059","article-title":"Advancements in cancer immunotherapies","volume":"11","author":"Roy","year":"2022","journal-title":"Vaccines (Basel)"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452400469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452400469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:35:43Z","timestamp":1726634143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452400469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S004113452400469X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.08.028","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Cytomegalovirus Reactivation in Children After Allogeneic Hematopoietic Cell Transplantation in 2 Transplant Eras","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}